Literature DB >> 18701632

Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.

Laura G Sánchez-Lozada1, Virgilia Soto, Edilia Tapia, Carmen Avila-Casado, Yuri Y Sautin, Takahiko Nakagawa, Martha Franco, Bernardo Rodríguez-Iturbe, Richard J Johnson.   

Abstract

Endothelial dysfunction is a characteristic feature during the renal damage induced by mild hyperuricemia. The mechanism by which uric acid reduces the bioavailability of intrarenal nitric oxide is not known. We tested the hypothesis that oxidative stress might contribute to the endothelial dysfunction and glomerular hemodynamic changes that occur with hyperuricemia. Hyperuricemia was induced in Sprague-Dawley rats by administration of the uricase inhibitor, oxonic acid (750 mg/kg per day). The superoxide scavenger, tempol (15 mg/kg per day), or placebo was administered simultaneously with the oxonic acid. All groups were evaluated throughout a 5-wk period. Kidneys were fixed by perfusion and afferent arteriole morphology, and tubulointerstitial 3-nitrotyrosine, 4-hydroxynonenal, NOX-4 subunit of renal NADPH-oxidase, and angiotensin II were quantified. Hyperuricemia induced intrarenal oxidative stress, increased expression of NOX-4 and angiotensin II, and decreased nitric oxide bioavailability, systemic hypertension, renal vasoconstriction, and afferent arteriolopathy. Tempol treatment reversed the systemic and renal alterations induced by hyperuricemia despite equivalent hyperuricemia. Moreover, because tempol prevented the development of preglomerular damage and decreased blood pressure, glomerular pressure was maintained at normal values as well. Mild hyperuricemia induced by uricase inhibition causes intrarenal oxidative stress, which contributes to the development of the systemic hypertension and the renal abnormalities induced by increased uric acid. Scavenging of the superoxide anion in this setting attenuates the adverse effects induced by hyperuricemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18701632      PMCID: PMC2576157          DOI: 10.1152/ajprenal.00104.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  57 in total

Review 1.  Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?

Authors:  Sofia G Tsouli; Evangelos N Liberopoulos; Dimitri P Mikhailidis; Vasilios G Athyros; Moses S Elisaf
Journal:  Metabolism       Date:  2006-10       Impact factor: 8.694

2.  Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde.

Authors:  J W Viets; W M Deen; J L Troy; B M Brenner
Journal:  Anal Biochem       Date:  1978-08-01       Impact factor: 3.365

3.  Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages.

Authors:  D L Granger; J B Hibbs; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

Review 4.  NADPH oxidases in the kidney.

Authors:  Pritmohinder S Gill; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2006 Sep-Oct       Impact factor: 8.401

5.  Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury.

Authors:  J L Simons; A P Provoost; S Anderson; H G Rennke; J L Troy; B M Brenner
Journal:  Kidney Int       Date:  1994-08       Impact factor: 10.612

Review 6.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production.

Authors:  T Sütö; G Losonczy; C Qiu; C Hill; L Samsell; J Ruby; N Charon; R Venuto; C Baylis
Journal:  Kidney Int       Date:  1995-10       Impact factor: 10.612

8.  Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system.

Authors:  Dalila B Corry; Pirooz Eslami; Kei Yamamoto; Michael D Nyby; Hirofumi Makino; Michael L Tuck
Journal:  J Hypertens       Date:  2008-02       Impact factor: 4.844

9.  Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.

Authors:  Laura G Sánchez-Lozada; Edilia Tapia; Virgilia Soto; Carmen Avila-Casado; Martha Franco; Lin Zhao; Richard J Johnson
Journal:  Nephrol Dial Transplant       Date:  2007-11-29       Impact factor: 5.992

Review 10.  Serum urate as an antioxidant for ascorbic acid.

Authors:  A Sevanian; K J Davies; P Hochstein
Journal:  Am J Clin Nutr       Date:  1991-12       Impact factor: 7.045

View more
  127 in total

1.  Epidemiology: Gout--bad for the heart as well as the joint.

Authors:  Alexander So
Journal:  Nat Rev Rheumatol       Date:  2010-07       Impact factor: 20.543

2.  Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations.

Authors:  Richard J Johnson; Miguel A Lanaspa; Eric A Gaucher
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

3.  Uric acid and chronic kidney disease: A time to act?

Authors:  Gianni Bellomo
Journal:  World J Nephrol       Date:  2013-05-06

4.  Rehydration with soft drink-like beverages exacerbates dehydration and worsens dehydration-associated renal injury.

Authors:  Fernando E García-Arroyo; Magdalena Cristóbal; Abraham S Arellano-Buendía; Horacio Osorio; Edilia Tapia; Virgilia Soto; Magdalena Madero; Miguel A Lanaspa; Carlos Roncal-Jiménez; Lise Bankir; Richard J Johnson; Laura-Gabriela Sánchez-Lozada
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-06       Impact factor: 3.619

5.  Both hyperthermia and dehydration during physical work in the heat contribute to the risk of acute kidney injury.

Authors:  Christopher L Chapman; Blair D Johnson; Nicole T Vargas; David Hostler; Mark D Parker; Zachary J Schlader
Journal:  J Appl Physiol (1985)       Date:  2020-02-20

6.  Uric acid level and erectile dysfunction in patients with coronary artery disease.

Authors:  Yalcin Solak; Hakan Akilli; Mehmet Kayrak; Alpay Aribas; Abduzhappar Gaipov; Suleyman Turk; Santos E Perez-Pozo; Adrian Covic; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Sex Med       Date:  2013-09-25       Impact factor: 3.802

7.  Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease.

Authors:  Fatemeh Ghane Sharbaf; Farahnak Assadi
Journal:  Pediatr Nephrol       Date:  2018-03-16       Impact factor: 3.714

8.  Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in InsAkita diabetic mice.

Authors:  Seiji Itano; Hiroyuki Kadoya; Minoru Satoh; Takashi Nakamura; Takayo Murase; Tamaki Sasaki; Yashpal S Kanwar; Naoki Kashihara
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-21

9.  Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4.

Authors:  Gholamreza Fazeli; Helga Stopper; Reinhard Schinzel; Chih-Wen Ni; Hanjoong Jo; Nicole Schupp
Journal:  Mutagenesis       Date:  2012-07-27       Impact factor: 3.000

Review 10.  Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?

Authors:  Angelo L Gaffo; N Lawrence Edwards; Kenneth G Saag
Journal:  Arthritis Res Ther       Date:  2009-08-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.